{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:49:44Z","timestamp":1790801384932,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24ek0109705"],"award-info":[{"award-number":["24ek0109705"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["JPMH24FC1008"],"award-info":[{"award-number":["JPMH24FC1008"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.braindev.2025.104383","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:01:27Z","timestamp":1750460487000},"page":"104383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular pathologies and therapies for Pelizaeus-Merzbacher disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Ken","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.braindev.2025.104383_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41582-020-00432-1","article-title":"Hypomyelinating leukodystrophies - unravelling myelin biology","volume":"17","author":"Wolf","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.braindev.2025.104383_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-004-0207-y","article-title":"PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2","volume":"6","author":"Inoue","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.braindev.2025.104383_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-981-32-9636-7_13","article-title":"Pelizaeus-Merzbacher disease: molecular and cellular pathologies and associated phenotypes","volume":"1190","author":"Inoue","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.braindev.2025.104383_bb0020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/acn3.203","article-title":"Altered PLP1 splicing causes hypomyelination of early myelinating structures","volume":"2","author":"Kevelam","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"issue":"16","key":"10.1016\/j.braindev.2025.104383_bb0025","doi-asserted-by":"crossref","first-page":"5665","DOI":"10.1073\/pnas.84.16.5665","article-title":"Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin","volume":"84","author":"Nave","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.braindev.2025.104383_bb0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/302483","volume":"65","author":"Mimault","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.braindev.2025.104383_bb0035","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00415-014-7263-5","article-title":"Epidemiological, clinical, and genetic landscapes of hypomyelinating leukodystrophies","volume":"261","author":"Numata","year":"2014","journal-title":"J Neurol"},{"issue":"Pt 4","key":"10.1016\/j.braindev.2025.104383_bb0040","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/brain\/awh409","article-title":"Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease","volume":"128","author":"Wolf","year":"2005","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.braindev.2025.104383_bb0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0896-6273(94)90214-3","article-title":"Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage","volume":"12","author":"Readhead","year":"1994","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.braindev.2025.104383_bb0050","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0896-6273(94)90358-1","article-title":"Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene","volume":"13","author":"Kagawa","year":"1994","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.braindev.2025.104383_bb0055","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/jhg.2012.71","article-title":"Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication","volume":"57","author":"Shimojima","year":"2012","journal-title":"J Hum Genet"},{"issue":"5","key":"10.1016\/j.braindev.2025.104383_bb0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bpa.12571","article-title":"Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease","volume":"28","author":"Ruiz","year":"2018","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.braindev.2025.104383_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1083\/jcb.200110138","article-title":"Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes\/lysosomes: implications for Pelizaeus-Merzbacher disease","volume":"157","author":"Simons","year":"2002","journal-title":"J Cell Biol"},{"issue":"7825","key":"10.1016\/j.braindev.2025.104383_bb0070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41586-020-2494-3","article-title":"Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease","volume":"585","author":"Elitt","year":"2020","journal-title":"Nature"},{"issue":"10063","key":"10.1016\/j.braindev.2025.104383_bb0075","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"issue":"437","key":"10.1016\/j.braindev.2025.104383_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.braindev.2025.104383_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125052","article-title":"Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.braindev.2025.104383_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pediatrneurol.2023.11.014","article-title":"An open-label Administration of Bioavailable- Form Curcumin in patients with Pelizaeus-Merzbacher disease","volume":"151","author":"Yamamoto","year":"2024","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.braindev.2025.104383_bb0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00401-019-01985-2","article-title":"Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease","volume":"138","author":"Stumpf","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"24","key":"10.1016\/j.braindev.2025.104383_bb0100","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.1523\/JNEUROSCI.16-24-07920.1996","article-title":"Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice","volume":"16","author":"Jung","year":"1996","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.braindev.2025.104383_bb0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ng0896-422","article-title":"A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease","volume":"13","author":"Gow","year":"1996","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.braindev.2025.104383_bb0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0896-6273(02)01045-0","article-title":"The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease","volume":"36","author":"Southwood","year":"2002","journal-title":"Neuron"},{"issue":"5852","key":"10.1016\/j.braindev.2025.104383_bb0115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1146361","article-title":"IRE1 signaling affects cell fate during the unfolded protein response","volume":"318","author":"Lin","year":"2007","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.braindev.2025.104383_bb0120","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.stemcr.2014.03.007","article-title":"Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes","volume":"2","author":"Numasawa-Kuroiwa","year":"2014","journal-title":"Stem Cell Rep"},{"issue":"11","key":"10.1016\/j.braindev.2025.104383_bb0125","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1074\/jbc.M112.435388","article-title":"Depletion of molecular chaperones from the endoplasmic reticulum and fragmentation of the Golgi apparatus associated with pathogenesis in Pelizaeus-Merzbacher disease","volume":"288","author":"Numata","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2025.104383_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2017.00007","article-title":"Cellular pathology of Pelizaeus-Merzbacher disease involving chaperones associated with endoplasmic reticulum stress","volume":"4","author":"Inoue","year":"2017","journal-title":"Front Mol Biosci"},{"issue":"4","key":"10.1016\/j.braindev.2025.104383_bb0135","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1471-4159.2007.04541.x","article-title":"Minimal role for caspase 12 in the unfolded protein response in oligodendrocytes in vivo","volume":"101","author":"Sharma","year":"2007","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.braindev.2025.104383_bb0140","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1111\/j.1471-4159.2007.04646.x","article-title":"Minimal role for activating transcription factor 3 in the oligodendrocyte unfolded protein response in vivo","volume":"102","author":"Sharma","year":"2007","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.braindev.2025.104383_bb0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.stem.2019.09.003","article-title":"Oligodendrocyte death in Pelizaeus-Merzbacher disease is rescued by Iron chelation","volume":"25","author":"Nobuta","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"155","key":"10.1016\/j.braindev.2025.104383_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004373","article-title":"Neural stem cell engraftment and myelination in the human brain","volume":"4","author":"Gupta","year":"2012","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.braindev.2025.104383_bb0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.stemcr.2019.07.002","article-title":"Long-term safety, immunologic response, and imaging outcomes following neural stem cell transplantation for Pelizaeus-Merzbacher disease","volume":"13","author":"Gupta","year":"2019","journal-title":"Stem Cell Rep"},{"issue":"4","key":"10.1016\/j.braindev.2025.104383_bb0160","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/342728","article-title":"Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females","volume":"71","author":"Inoue","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.braindev.2025.104383_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ng0394-257","article-title":"X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus","volume":"6","author":"Saugier-Veber","year":"1994","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.braindev.2025.104383_bb0170","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1006\/bbrc.1995.2539","article-title":"Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males","volume":"215","author":"Osaka","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.braindev.2025.104383_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0896-6273(01)80046-5","article-title":"Assembly of CNS myelin in the absence of proteolipid protein","volume":"18","author":"Klugmann","year":"1997","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.braindev.2025.104383_bb0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0896-6273(00)80360-8","article-title":"Proteolipid protein is necessary in peripheral as well as central myelin","volume":"19","author":"Garbern","year":"1997","journal-title":"Neuron"},{"issue":"Pt 3","key":"10.1016\/j.braindev.2025.104383_bb0185","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/brain\/awf043","article-title":"Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation","author":"Garbern","year":"2002","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.braindev.2025.104383_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archneurol.2011.1030","article-title":"Novel hypomyelinating leukoencephalopathy affecting early myelinating structures","volume":"69","author":"Steenweg","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2025.104383_bb0195","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.omtn.2018.05.019","article-title":"Morpholino antisense oligomers as a potential therapeutic option for the correction of alternative splicing in PMD, SPG2, and HEMS","volume":"12","author":"Tantzer","year":"2018","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:31:29Z","timestamp":1765456289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760425000658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0387760425000658"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104383","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathologies and therapies for Pelizaeus-Merzbacher disease","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104383"}}